Abstract
SummaryAnaphylaxis is an acute allergic response that can be life‐threatening if not recognised and treated appropriately. Neuromuscular blocking agents (NMBAs) are commonly associated with anaphylaxis during anaesthesia. Confirmation of allergy to NMBAs is by intradermal testing, and cross‐reactivity is seen between different drugs. We present a case of anaphylaxis at induction of anaesthesia with subsequent investigation showing allergy to all NMBAS, which has not previously been reported in the literature. The presentation and treatment of this patient are largely in keeping with the recent guidelines produced from the Royal College of Anaesthetists' 6th National Audit Project report, however, we highlight areas where it diverges in part, with a good outcome for the patient.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
